Holen Sie sich die Stockscreener-App
4.40
0.45%
-0.02
Handel nachbörslich:
4.40
Finanzdaten der Inmune Bio Inc-Aktie (INMB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
50.00%
0.014
|
0.028 | 0.043 | 0.046 | 0.038 |
Operating Expenses
|
31.21%
11.03
|
8.407 | 8.571 | 6.457 | 6.461 |
| Interest Income/Expense |
0.357
|
- | - | - | - |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
31.21%
11.03
|
8.407 | 8.571 | 6.457 | 6.461 |
| Operating Income/Loss |
31.48%
-11.02
|
-8.379 | -8.528 | -6.411 | -6.423 |
| Income/Loss From Continuing Operations Before Tax |
50.00%
0.014
|
0.028 | 0.043 | -6.501 | -6.536 |
| Income/Loss From Continuing Operations After Tax |
31.13%
-11.03
|
-8.408 | -8.563 | -6.501 | -6.536 |
|
Net Income/Loss
|
31.13%
-11.03
|
-8.408 | -8.563 | -6.501 | -6.536 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
130.52K%
18.03
|
0.0138 | 18.01 | 17.95 | 17.95 |
| Diluted Average Shares |
130.52K%
18.03
|
0.0138 | 18.01 | 17.95 | 17.95 |
| Basic Earnings Per Share |
29.79%
-0.61
|
-0.47 | -0.48 | -0.36 | -0.36 |
| Diluted Earnings Per Share |
29.79%
-0.61
|
-0.47 | -0.48 | -0.36 | -0.36 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):